Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
SurgePays Inc (SURG)
NASDAQCommunication ServicesSoftware - ApplicationSnapshot 2026-11-05
$0.16+5.05%
Close 2026-11-05 · 1-day change
NASDAQCommunication ServicesSoftware - ApplicationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.01 → 0.01 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for SURG yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Meet Nasdaq listing requirements | A supporting condition in SurgePays Inc's published investment case. The stated target is Maintain minimum market value of listed securities per Nasdaq rules. | Under Pressure | Failure to meet Nasdaq listing requirements leads to delisting | Nasdaq bid price < $1.00 (target >= $1.00) Nasdaq notified SurgePays of bid price deficiency and granted 180 days to regain compliance by March 2027. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business, not a proven compounder, because it is loss-making and management execution is rated volatile. The long-term thesis is on watch: revenue and subscriber growth are on track, but recent performance trails its industry cohort and the risk level remains elevated.
The valuation model signals that SURG is cheap versus peers, but confidence in that comparison is low. The priced-in tag is justified and the fragility tier is low, while the negative expectations gap points to a demanding setup in which weaker results could matter; the evidence does not spell out exactly what growth the market assumes.
Near term, the repeated earnings misses and high estimated chance of another miss make results and guidance key risks. Over the multi-year view, point-of-sale and prepaid services have driven substantial revenue and subscriber growth, while lower general and administrative costs show some cost discipline; the stated cost-reduction priority is still behind. Recent delisting-rule and auditor-change notices add uncertainty, while a completed acquisition may affect execution.
The unfavorable case is a guidance cut or another weak earnings report, which would reinforce the existing execution concerns. Favorable factors include rate cuts and continued strong results from sector bellwethers, which may support the broader sector. The thesis also hinges on sustained subscriber and revenue growth, better cost control, and resolution of listing-related concerns.
Over the next 1 to 3 years, SURG’s growth initiatives offer a clear business opportunity, but the loss-making profile, earnings record, and recent regulatory and listing events make execution the central test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Manage capital allocation and liquidity |
| A supporting condition in SurgePays Inc's published investment case. The stated target is Maintain sufficient liquidity to fund operations through FY26. |
| Intact |
| Liquidity shortfall or inability to service debt |
Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Manage and reduce operating losses | A primary condition in SurgePays Inc's published investment case. The stated target is Operating loss improves toward zero by FY27. | Intact | Operating losses worsen or remain above $10M through FY26 | Operating income: $3.452M FY2026-Q2; GAAP. Published target: Operating loss improves toward zero by FY27. Target period ends 2027-12-31; this observation covers 2026-Q2. Aug 19, 20263,452,447 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth through point of sale and prepaid services | SurgePays aims to grow revenue through prepaid services, targeting $16M+ in 2026. | Intact | Revenue falls below $16M in FY26 | Revenue: $16.205M FY2026-Q2; GAAP. Published target: >= $16M revenue in FY26. Target period ends 2026-12-31; this observation covers 2026-Q2. Aug 19, 202616,204,821 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.05 → $0.01 · observed estimates
$0.08B → $0.07B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-07-25 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-07-26 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-07-27 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-07-28 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-07-29 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-07-30 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-07-31 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-01 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-02 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-03 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-04 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-05 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-06 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-08 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-09 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-10 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-12 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-13 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-14 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-15 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-16 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-17 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-18 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-19 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-20 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-21 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-22 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-23 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-24 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-25 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-26 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-27 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-28 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-29 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-30 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-08-31 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-01 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-02 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-03 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-04 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-05 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-06 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-07 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-08 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-09 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-10 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-11 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-12 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-13 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-14 | $0.05 | $80,100,000 | 1 / 1 |
| 2026-09-15 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-16 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-17 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-18 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-19 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-20 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-21 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-22 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-23 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-24 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-25 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-26 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-27 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-28 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-29 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-09-30 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-01 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-02 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-03 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-04 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-05 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-06 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-07 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-08 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-09 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-10 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-11 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-12 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-13 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-14 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-15 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-16 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-17 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-18 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-19 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-20 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-21 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-22 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-23 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-24 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-25 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-26 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-27 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-28 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-29 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-30 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-10-31 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-11-01 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-11-02 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-11-03 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-11-04 | $0.01 | $70,100,000 | 1 / 1 |
| 2026-11-05 | $0.01 | $70,100,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.